Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001640334-25-002225
Filing Date
2025-11-28
Accepted
2025-11-26 20:35:55
Documents
87
Period of Report
2025-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q lxrp_10k.htm   iXBRL 10-K 1399872
2 ENGAGEMENT AGREEMENT lxrp_ex1011.htm EX-10.11 49519
3 CONSENT lxrp_ex231.htm EX-23.1 1595
4 CERTIFICATION lxrp_ex311.htm EX-31.1 9274
5 CERTIFICATION lxrp_ex312.htm EX-31.2 9496
6 CERTIFICATION lxrp_ex321.htm EX-32.1 4910
7 CERTIFICATION lxrp_ex322.htm EX-32.2 5113
13 lxrp_ex1011img1.jpg GRAPHIC 8936
  Complete submission text file 0001640334-25-002225.txt   6424431

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA lxrp-20250831.xsd EX-101.SCH 65407
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE lxrp-20250831_lab.xml EX-101.LAB 359576
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lxrp-20250831_cal.xml EX-101.CAL 51979
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lxrp-20250831_pre.xml EX-101.PRE 300780
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lxrp-20250831_def.xml EX-101.DEF 151950
90 EXTRACTED XBRL INSTANCE DOCUMENT lxrp_10k_htm.xml XML 973853
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-K | Act: 34 | File No.: 001-39874 | Film No.: 251532071
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)